| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physical-Chemistry, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Buenos Aires, Argentina
2 Laboratory of Experimental Medicine, Hospital Aleman, Buenos Aires, Buenos Aires, Argentina
3 Physiology, Ponce School of Medicine, Ponce, Ponce, Puerto Rico
4 Experimental Nephrology, Institute of Cardiovascular Research, School of Medicine, University of Buenos Aires, Buenos Aires, Buenos Aires, Argentina
* To whom correspondence should be addressed. E-mail: felinserra{at}yahoo.com.ar.
Mitochondrial dysfunction is associated with cardiovascular damage; however, data on a possible
association with kidney damage are scarce. Here we aimed at investigating whether a) kidney impairment is related to mitochondrial dysfunction, and b) angiotensin II blockade, as compared to Ca2+-channel blockade, can reverse potential mitochondrial changes in hypertension. Eight-weekold male spontaneously hypertensive rats (SHR) received water containing losartan (40 mg/kg/day, SHR+Los), Amlodipine (3 mg/kg/day, SHR+Amlo), or no-additions (SHR) for 6-months. Wistar-Kyoto rats (WKY) were normotensive controls. Glomerular and tubulointerstitial damage, systolic blood pressure, and proteinuria were higher, and creatinine clearance was lower in SHR versus SHR+Los and WKY. In SHR+Amlo, blood pressure was similar to WKY, kidney function was similar to SHR, and renal lesions were lower than in SHR, but higher than in SHR+Los. In kidney mitochondria from SHR and SHR+Amlo, membrane potential, nitric oxide synthase, Mnsuperoxide dismutase and cytochrome oxidase activities, and uncoupling protein-2 content were lower than in SHR+Los and WKY. In SHR and SHR+Amlo, mitochondrial hydrogen peroxide production was higher than in SHR+Los and WKY. Renal glutathione content was higher in SHR and SHR+Amlo relative to SHR+Los and WKY, but in the latter groups glutathione was relatively more reduced. Tubulointerstitial 
-smooth muscle actin labeling was inversely related to Mnsuperoxide dismutase activity and UCP2 content. These findings suggest that oxidant stress is associated with renal mitochondrial dysfunction in SHR. The mitochondrial-antioxidant actions of losartan may be an additional or alternative way to explain some of the beneficial effects of AT1-receptor antagonists.
This article has been cited by other articles:
|
|
 |
|
  M. Mitsuishi, K. Miyashita, A. Muraki, and H. Itoh Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control Diabetes, March 1, 2009; 58(3): 710 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. de Cavanagh, M. Ferder, F. Inserra, and L. Ferder Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H550 - H558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Elks, N. Mariappan, M. Haque, A. Guggilam, D. S. A. Majid, and J. Francis Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR Am J Physiol Renal Physiol, February 1, 2009; 296(2): F298 - F305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H.H. Chan, K. L.H. Wu, A. Y.W. Chang, M.-H. Tai, and J. Y.H. Chan Oxidative Impairment of Mitochondrial Electron Transport Chain Complexes in Rostral Ventrolateral Medulla Contributes to Neurogenic Hypertension Hypertension, February 1, 2009; 53(2): 217 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Doughan, D. G. Harrison, and S. I. Dikalov Molecular Mechanisms of Angiotensin II-Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction Circ. Res., February 29, 2008; 102(4): 488 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. V. de Cavanagh, L. Ferder, J. E. Toblli, B. Piotrkowski, I. Stella, C. G. Fraga, and F. Inserra Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H456 - H465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Piotrkowski, C. G. Fraga, and E. M. V. de Cavanagh Mitochondrial function and nitric oxide metabolism are modified by enalapril treatment in rat kidney Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1494 - R1501. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
